Condition
Infraclavicular Brachial Plexus Block
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Unknown2
Active Not Recruiting1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07386327Not ApplicableRecruitingPrimary
Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes
NCT06769581Not ApplicableActive Not RecruitingPrimary
The Effect of Dexamethasone Adjuvant to Varying Doses of Bupivacaine on Motor and Sensory Blockade in Infraclavicular Brachial Plexus Blockade
NCT03824717Not ApplicableUnknownPrimary
MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks
NCT00993746Phase 4UnknownPrimary
2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula
Showing all 4 trials